News

Fintel reports that on July 11, 2025, Argus Research initiated coverage of CoreWeave (NasdaqGS:CRWV) with a Buy ...
Solventum Corporation (NYSE:SOLV) is one of the 15 successful spin-off companies. On July 1, analysts at Argus Research ...
Argus initiated its coverage on the hyperscaler CoreWeave (CRWV) with a Buy rating due in part to its ability to take ...
CoreWeave (CRWV) stock is sliding despite being initiated at Argus with a Buy rating and $200 price target. Freedom Capital Markets chief global strategist Jay Woods joins Market Domination with Josh ...
Fintel reports that on July 1, 2025, Argus Research upgraded their outlook for NIKE (NYSE:NKE) from Hold to Buy. Analyst ...
Rising data center demand to trade issues and interest rates - the industrials sector has many potential catalysts. Argus ...
Major U.S. banks are expected to report stronger profits next week, driven by buoyant trading and a modest rebound in ...
A research and development team from Bradford NHS Trust is helping to improve research and governance systems in Afghanistan and Pakistan.
Paediatricians and families have been left reeling after BF&M and Argus Insurance removed Boston Children’s Hospital from its ...
Major U.S. banks are expected to report stronger profits next week, driven by buoyant trading and a modest rebound in ...
Detailed price information for Mccormick & Company (MKC-N) from The Globe and Mail including charting and trades.
On June 18, Argus Research upped its intermediate-term rating on Jabil Inc. (NYSE:JBL)’s stock to “Buy” from “Hold” with a price objective of $230.